Peripheral Intravenous Catheters Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Conventional and Safety Catheters

Global Peripheral Intravenous Catheter Market Report to 2032

The global peripheral intravenous catheter market was valued at $1.7 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching $1.9 billion by 2032.

This report covers the global market for peripheral intravenous catheters (PIVCs), including conventional and safety PIVCs used across acute care and alternate care settings.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by educational placement, ultrasound-guided PIVC kits, safety device conversion, and continued use of PIVCs across healthcare settings. However, specialized securement devices and increasing PIVC dwell times are reducing the number of catheters used per patient, limiting stronger market expansion.

Market Overview

The global peripheral intravenous catheter market includes short-term vascular access devices used for medication delivery, fluid administration, blood draws, and routine hospital care.

The market is segmented into conventional and safety PIVCs. Safety PIVCs are designed to protect healthcare professionals and patients against needlestick injuries. The safety segment includes blood control PIVCs, which help protect against blood splatter, and non-blood control PIVCs.

The market is also segmented by care setting, including acute care and alternate care. PIVCs are among the most commonly used vascular access devices, making them a high-volume product category across hospitals, clinics, emergency departments, and other treatment settings.

PIVC dwell times continue to lengthen as clinically indicated removal becomes more widely adopted. Instead of replacing catheters on a fixed schedule, PIVCs are increasingly removed only when a complication occurs or therapy ends. This reduces unnecessary line replacements and lowers the number of PIVCs used per patient, constraining unit volume growth despite widespread use.

Market Drivers

Placement for Educational Purposes

PIVC placement for educational purposes continues to support unit demand. Physicians, nurses, and other healthcare professionals require ongoing training in vascular access techniques.

This is especially relevant for specialized placement methods, including ultrasound-guided insertion. As clinicians receive training, additional PIVCs may be used during education, simulation, and supervised practice.

Although PIVC dwell time trends are reducing the number of catheters used per patient, educational use helps moderate the effect of that decline. Training-related placements support continued demand for PIVCs, particularly in hospitals and care settings where staff are learning new insertion techniques.

Ultrasound-Guided PIVC Kits

Ultrasound-guided PIVC kits are another driver of market value. Historically, PIVCs were not commonly sold in kits. In November 2015, B. Braun launched the Ster-ASSIST(TM) Peripheral IV Catheter Insertion Kit, which includes components for ultrasound-guided PIVC insertion.

The kit includes sterile ultrasound gel, an ultrasound probe cover, and a long Introcan Safety(R) PIVC. These kits generally command a price premium over standalone PIVCs, with purchase order data indicating that ASPs for such kits can exceed $200.

Adoption of PIVC kits is linked to the volume of PIVC insertions performed using ultrasound guidance. Emergency room physicians, who already use ultrasound to guide placement of other catheter types, represent one potential adoption group. If ultrasound-guided PIVC insertion becomes more common, premium kits could support market value growth.

Safety and Blood Control Conversion

Safety PIVCs continue to support the market by reducing needlestick injury risk. These devices include built-in safety mechanisms that protect healthcare professionals and patients after insertion.

Blood control PIVCs provide an additional benefit by helping reduce blood splatter during placement. This can improve clinician experience, reduce cleanup, and support safer workflows in high-volume settings.

As safety and blood control devices replace conventional PIVCs, the market benefits from higher ASP products. While conversion is advanced in many developed regions, remaining adoption opportunities in less mature markets and ongoing product upgrades can continue supporting market value.

Market Limiters

Specialized PIVC Securement Devices

Specialized PIVC securement devices are an important limiter for the PIVC market. An unscheduled restart occurs when a new PIVC must be inserted after one or more previous devices fail.

Approximately 40% to 70% of total PIVC insertions are attributed to unscheduled restarts. Specialized PIVC securement devices are designed to reduce these failures by improving catheter stability.

As penetration of specialized securement devices increases, the volume of unscheduled restarts is expected to decline. This reduces the number of PIVCs used per patient and limits growth in the total PIVC market.

Increased PIVC Dwell Time

Increased dwell time is another major restraint. Longer dwell times mean fewer PIVCs are used per patient over the course of care.

This trend is driven by clinically indicated removal, a policy that recommends removing catheters only when a complication occurs or therapy ends, rather than on a fixed schedule.

While this approach reduces unnecessary replacements and improves care efficiency, it also lowers total unit consumption. As clinically indicated removal becomes more common, unit sales growth will remain constrained.

Mature High-Volume Demand

The PIVC market is a mature, high-volume category. PIVCs are widely used across care settings, and most hospitals already rely on them as a standard vascular access tool.

Because the product is already broadly adopted, growth is less dependent on new users and more dependent on product mix, safety conversion, and premium technologies such as blood control and ultrasound-guided kits.

This maturity limits rapid expansion. Even when market value grows, much of the growth is expected to come from higher-value device categories rather than strong increases in total catheter volume.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
• Device scope: The report covers peripheral intravenous catheters, including conventional and safety PIVCs. The safety segment includes blood control and non-blood control PIVCs. The market is also analyzed across acute care and alternate care settings.

Markets Covered and Segmentation

Peripheral Intravenous Catheter Market

• Device type: Conventional and safety.

Conventional PIVCs are standard peripheral intravenous catheters used for short-term vascular access. These products remain part of the global market, particularly in cost-sensitive settings, but their share has declined in regions where safety device conversion is advanced.

Safety PIVCs are designed to reduce needlestick injury risk. These products are increasingly standard in many healthcare settings and include both blood control and non-blood control variants.

Blood control PIVCs are designed to protect against blood splatter during insertion and use. These devices support safer and cleaner clinical workflows and typically command higher ASPs than basic conventional devices.

Non-blood control safety PIVCs include safety mechanisms to reduce needlestick injury risk but do not include the same blood control functionality.

• Care setting: Acute care and alternate care.

Acute care settings include hospitals and emergency departments where PIVCs are used at high volume for immediate and short-term access. Alternate care settings include outpatient, clinic, and non-hospital care environments where PIVCs may be used for selected treatments.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

Competitive Analysis

In 2025, Becton Dickinson led the global PIVC market. The company has played a major role in the conversion to safety and blood control PIVCs.

BD's offerings cover major segments of the market, and the company is the leader of the non-blood control safety segment, driven largely by sales of Insyte(R) Autoguard(R) catheters. In the blood control segment, BD sells Nexiva(TM) devices and Insyte(R) Autoguard(R) BC.

B. Braun competes in the safety PIVC market through products such as Introcan Safety(R) IV catheters and Introcan Safety(R) 3 closed IV catheters. These devices resemble conventional PIVCs while offering automatic and unbypassable safety features.

B. Braun has gained share partly through lower-priced PIVCs. Its Ster-ASSIST(TM) peripheral IV catheter insertion kit also aligns with the trend toward ultrasound-guided PIVC insertion, even without major organization-wide endorsements for ultrasound guidance.

ICU Medical ranked third in the PIVC market in 2025. The company offers both conventional and safety products. Jelco(R) ProtectIV(R) competes with BD's Insyte(R) Autoguard(R) in the safety segment. ICU Medical's acquisition of Smiths Medical strengthened its position, while OPTIVA(R), made from Ocrilon(R) polyurethane, is designed to reduce phlebitis risk.

Technology and Practice Trends

Safety PIVC Adoption

Safety PIVCs continue to replace conventional products in many markets. These devices reduce needlestick injury risk and support safer clinical workflows.

Safety conversion remains an important source of product mix improvement, especially in markets where conventional devices are still used.

Blood Control Technology

Blood control PIVCs are gaining importance because they help reduce blood splatter during insertion. This improves user experience and supports infection control and workflow efficiency.

These devices generally command higher ASPs than basic safety PIVCs.

Clinically Indicated Removal

Clinically indicated removal is changing utilization patterns. PIVCs are increasingly removed when therapy ends or when complications occur, rather than according to fixed replacement schedules.

This improves care efficiency but reduces the number of PIVCs used per patient.

Ultrasound-Guided Insertion

Ultrasound-guided PIVC insertion is becoming more relevant for patients with difficult vascular access. Kits designed for ultrasound-guided insertion can command meaningful price premiums.

Adoption depends on training, physician and nurse preference, and the frequency of ultrasound-guided PIVC placement.

Securement Device Impact

Specialized securement devices are reducing unscheduled restarts. By helping keep catheters stable, these products lower the number of failed lines and repeat insertions.

This benefits patient care but limits PIVC unit demand.

Material Improvements

Material improvements continue to support device performance. ICU Medical's OPTIVA(R) catheter, made from Ocrilon(R) polyurethane, is an example of product design aimed at reducing phlebitis risk.

Improved materials can help differentiate products in a mature market.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global peripheral intravenous catheter market today, and how much is it expected to grow through 2032?
• How are conventional and safety PIVC segments performing across the forecast period?
• How are unit sales, procedure numbers, ASPs, and market values changing over time?
• What role do blood control PIVCs play in product mix and ASP growth?
• How is clinically indicated removal affecting PIVC dwell time and unit demand?
• Why are specialized securement devices reducing unscheduled restarts?
• How are ultrasound-guided PIVC kits influencing premium product adoption?
• What role does training and educational placement play in ongoing catheter demand?
• Which companies lead the global PIVC market?
• How are BD, B. Braun, and ICU Medical positioned across conventional, safety, blood control, and ultrasound-guided PIVC product categories?

The Global Peripheral Intravenous Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand safety conversion trends, and support commercial planning in the global PIVC market.